ClaimsFiler reminds Hims & Hers investors of the November 2, 2026 lead‑plaintiff deadline in the ongoing securities class action
Executive summary: ClaimsFiler reminded investors that they have until November 2, 2026 to file lead plaintiff applications in a securities class action lawsuit against Hims & Hers Health, Inc. The lead plaintiff deadline determines who can steer the litigation, influencing legal strategy, potential settlement amounts, and the company’s ongoing stock volatility.
Who is involved: Hims & Hers Health, Inc. (NYSE: HIMS), ClaimsFiler service, investors with losses exceeding $100,000, and potential lead plaintiff applicants.
Likely next: Investors may submit lead plaintiff applications before the November 2 deadline; the court will then select a lead plaintiff, after which pretrial proceedings and possible settlement talks are expected in early 2027.
ClaimsFiler issued a shareholder alert on September 5, 2026 notifying investors with losses over $100,000 that they have until November 2, 2026 to apply for lead plaintiff status in the securities class action against Hims & Hers Health, Inc. The reminder follows a series of similar alerts and regulatory scrutiny that began after the FTC’s privacy and billing complaint in August 2026, which triggered a sharp stock decline. The notice does not allege new wrongdoing but highlights the procedural deadline that could shape the lawsuit’s direction and potential costs for the company.
Timeline
- — Hims & Hers Health Shareholder Alert: ClaimsFiler Reminds Investors With Losses In Excess Of $100,000 Of Lead Plaintiff Deadline In Class Action Lawsuit Against Hims & Hers Health, Inc. - HIMS (PR Newswire)
- — Hims & Hers Health, Inc. (HIMS) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit (PR Newswire)
- — Hims & Hers Health (NYSE: HIMS) Faces Securities Class Action After FTC Lawsuit Reveal Drives Stock Sharply Lower -- HBSS (PR Newswire)
- — INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Hims & Hers Health, Inc. - HIMS (PR Newswire)
- — HIMS INVESTOR ALERT: Hims & Hers Health, Inc. Investors with Substantial Losses Have Opportunity to Lead the Hims & Hers Class Action Lawsuit (PR Newswire)
- — HIMS Investors Have Opportunity to Lead Hims & Hers Health, Inc. Securities Fraud Lawsuit (PR Newswire)
- — Hims & Hers (HIMS) CEO Says the FTC Doesn’t Understand His Own Company (Yahoo Finance)
- — Hims & Hers (HIMS)’ Weight‑Loss Plans Results Penalties Over Visa (V) Credit Card Disputes (Yahoo Finance)
- — Hims & Hers Health (NYSE: HIMS) Stock Plunges 14% Following Major FTC Lawsuit Over Privacy & Billing; Hagens Berman Investigates Corporate Compliance and Investor Ramifications (PR Newswire)
- — HIMS INVESTIGATION NOTICE: Kessler Topaz Meltzer & Check, LLP Encourages Hims & Hers Health, Inc. (NYSE: HIMS) Investors to Contact the Firm (PR Newswire)
Analysis — what this means
Likely next events
- Lead plaintiff application deadline: November 2, 2026
- ClaimsFiler reminder issued: September 5, 2026
- Potential court hearing on lead plaintiff selection: Q1 2027
Sectors affected
- Telehealth
- Direct‑to‑consumer prescription services
- Online wellness platforms
Regulatory implications
- SEC may increase scrutiny of telehealth advertising and claims under the Securities Exchange Act of 1934
- FTC could review alleged unfair billing practices under Section 5 of the FTC Act
Historical parallels
- 2021 Teladoc Health securities class action over forecasting claims
- 2020 FTC settlement with Ro over telehealth marketing practices
Key entities
Sources
Open the full interactive case file on Beyond →